Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award winner for research showing how leveraging advanced analytics with personalized outcome prediction tools can ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...

Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...

Vitalacy, Inc., a leader in patient safety technology, is proud to announce the launch of its AI-driven Virtual Care solution ...

The following is a summary of “Reliability of paramagnetic rim lesion detection at 1.5T MRI in multiple sclerosis patients,” ...

The trial comes as a new study highlighted differences in how genes are activated in brain tumour cells compared to healthy ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...

Therapists and union reps accuse the HMO giant of saddling workers with excessive caseloads while forcing patients to wait ...

The test provides a negative predictive value (NPV) of 92.5% and can help providers identify children who are unlikely to be ...

Sepsis caused one in five deaths globally in 2020, according to the WHO. Essentially, the world sees 11 million deaths due to ...